Skip to main content
All lobbying firms

RUBICON ADVISORS, LLC

Registrant on federal lobbying filings · filed 2025 to 2026

$1,892,000 Income reported
8 Clients represented
49 Filings counted
1 Former members lobbying

Income is the fees this registrant reported being paid to lobby. Everything on this page is grouped by the registrant's LDA id (315091), not by name.

 Clients 8
 Lobbyists named 1
  • WILLIAM BURKE 8 filings · through 2026 Former member of Congress

A lobbyist who previously held a covered government position must disclose it. We flag the ones whose name resolves to a member of Congress and link the ones still in our roster. The revolving door collects them across every firm.

 Reported by year 2 years
  • 2026 $624,000 16 filings
  • 2025 $1,268,000 33 filings
 Issues lobbied 2

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

 Agencies and chambers lobbied 8
  • Food & Drug Administration (FDA) 23
  • Health & Human Services, Dept of (HHS) 22
  • HOUSE OF REPRESENTATIVES 19
  • SENATE 19
  • Centers For Medicare and Medicaid Services (CMS) 12
  • Drug Enforcement Administration (DEA) 6
  • Natl Institutes of Health (NIH) 6
  • State, Dept of (DOS) 6
 Recent filings 49 total
Q2
APOE ALZHEIMERS ALLIANCE
2nd Quarter (Apr 1 - June 30) 2026 · posted Jul 20, 2026
View →
Q2
HENRY MEDS
2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $60,000 income · posted Jul 20, 2026
View →
Q2
IMMUNIZATION ALLIANCE FOR EQUITY AND ACCESS
2nd Quarter (Apr 1 - June 30) 2026 · $45,000 income · posted Jul 20, 2026
View →
Q2
ALZHEON
2nd Quarter (Apr 1 - June 30) 2026 · $12,000 income · posted Jul 20, 2026
View →
Q2
HYPOPARATHYROIDISM ASSOCIATION
2nd Quarter (Apr 1 - June 30) 2026 · posted Jul 20, 2026
View →
Q2
ASCENDIS PHARMA, INC.
2nd Quarter (Apr 1 - June 30) 2026 · $60,000 income · posted Jul 20, 2026
View →
Q2
DYNAVAX TECHNOLOGIES
2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $75,000 income · posted Jul 20, 2026
View →
Q2
DR. REDDY'S LABORATORIES, LTD
2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $60,000 income · posted Jul 20, 2026
View →
Q1
APOE ALZHEIMERS ALLIANCE
1st Quarter (Jan 1 - Mar 31) 2026 · posted Apr 23, 2026
View →
Q1
HENRY MEDS
1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $60,000 income · posted Apr 23, 2026
View →
Q1
IMMUNIZATION ALLIANCE FOR EQUITY AND ACCESS
1st Quarter (Jan 1 - Mar 31) 2026 · $45,000 income · posted Apr 23, 2026
View →
Q1
ALZHEON
1st Quarter (Jan 1 - Mar 31) 2026 · $12,000 income · posted Apr 23, 2026
View →
Q1
HYPOPARATHYROIDISM ASSOCIATION
1st Quarter (Jan 1 - Mar 31) 2026 · posted Apr 23, 2026
View →
Q1
ASCENDIS PHARMA, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · $60,000 income · posted Apr 23, 2026
View →
Q1
DR. REDDY'S LABORATORIES, LTD
1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $60,000 income · posted Apr 23, 2026
View →
Q1
DYNAVAX TECHNOLOGIES
1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $75,000 income · posted Apr 23, 2026
View →
Q4
APOE ALZHEIMERS ALLIANCE
4th Quarter (Oct 1 - Dec 31) 2025 · posted Jan 18, 2026
View →
Q4
HENRY MEDS
4th Quarter (Oct 1 - Dec 31) 2025 · House · Senate · $60,000 income · posted Jan 18, 2026
View →
Q4
IMMUNIZATION ALLIANCE FOR EQUITY AND ACCESS
4th Quarter (Oct 1 - Dec 31) 2025 · $45,000 income · posted Jan 18, 2026
View →
Q4
ALZHEON
4th Quarter (Oct 1 - Dec 31) 2025 · $12,000 income · posted Jan 18, 2026
View →

Showing the 20 most recent of 49 filings. Search the explorer for "RUBICON ADVISORS, LLC".

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.

Report a problem